Часто задаваемые вопросы

What is Copper Oxodotreotide used for?

A copper-labeled form of a somatostatin analog used to target tumors that express somatostatin receptors, such as certain prostate cancers. It delivers therapeutic or diagnostic payloads directly to cancer cells.

How does Copper Oxodotreotide work?

Competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway of cholesterol biosynthesis. This reduces intracellular cholesterol, upregulates LDL receptor expression, and lowers circulating LDL cholesterol.

Is Copper Oxodotreotide an approved drug?

Yes, Copper Oxodotreotide is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4302413. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.